Price and cost description for a course of Teclistamab treatment

Teritusumab (Teclistamab-cqyv) is an innovative bispecific antibody that has attracted much attention in the global field of multiple myeloma (MM) in recent years. Its cost issue has naturally become one of the most discussed focuses among patients. Since the drug is a highly complex biological agent with long production cycle, strict quality requirements and high technical barriers, its pricing is generally high both domestically and overseas. The actual cost of a course of treatment is often not a fixed number, but is affected by multiple factors such as drug dosage, length of treatment, patient weight, hospital charging standards, national policies and supply channels.

Overseas, the pricing of teritusumab is closely related to the dosage regimen. Since the drug is treated in a "gradually increasing dose + maintenance administration" method, intensive injections are required at the beginning of the treatment course to ensure safety and immune system adaptation, so the cost of medication is usually higher in the first few weeks. As it enters the maintenance period, the frequency of administration gradually increases, but overall it is still a long-term management drug, so the annual cost is still high. The actual medication expenses of many overseas patients include not only the drug itself, but also ancillary expenses such as hospitalization monitoring, injection procedures, immune response management, etc., further increasing the total cost.

In the domestic market, although teritusumab is already on the market, since it has not yet been included in the medical insurance catalog, patients still need to bear all the costs themselves. The price of each box of medicines is mostly in the range of tens of thousands of yuan, and the total cost of a course of treatment needs to be calculated based on the cumulative number of medications. If estimated based on the routine dosing rhythm, a course of treatment may span from several months to a year, making the overall cost likely to be as high as hundreds of thousands of yuan or more. However, because different medical institutions will incur additional management or injection costs according to their own service systems, the final cost may also vary significantly.

Reference materials:https://www.tecvayli.com/